Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool

• Hauptverfasser: Xiao-yi Bao (Verfasst von), Qun Zheng (Verfasst von), Qiang Tong (Verfasst von), Peng-chong Zhu (Verfasst von), Zhuang Zhuang (Verfasst von), Guo-qing Zheng (Verfasst von), Yan Wang (Verfasst von)
• Format: Buch
• Veröffentlicht: Frontiers Media S.A., 2018-12-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Background: Danshensu (DSS) possesses unique bioactivity on the cardiovascular system. However, there is a lack of systematical summary of DSS for acute myocardial ischemia injury and no quality assessment tool for the systematical review of cell experiments. Here, we aimed to assess the preclinical...